Up a level |
Love, Sharon B, Cafferty, Fay, Snowdon, Claire, Carty, Karen, Savage, Joshua, Pallmann, Philip, McParland, Lucy, Brown, Louise, Masters, Lindsey, Schiavone, Francesca et al (show 26 more authors)
(2022)
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units.
Trials, 23 (1).
p. 757.
Ng, Kenrick, Metcalf, Rob, Sacco, Joseph, Kong, Anthony, Wheeler, Graham, Forsyth, Sharon, Bhat, Reshma, Ward, Joseph, Ensell, Leah, Lowe, Helen et al (show 5 more authors)
(2023)
Protocol for the EACH trial: a multicentre phase II study evaluating the safety and antitumour activity of the combination of avelumab, an anti-PD-L1 agent, and cetuximab, as any line treatment for patients with recurrent/metastatic head and neck squamous cell cancer (HNSCC) in the UK.
BMJ open, 13 (11).
e070391-e070391.